Venture Life Group Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BFPM8908
GBP
0.61
0.01 (0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 5.77%

  • The company has been able to generate a Return on Capital Employed (avg) of 5.77% signifying low profitability per unit of total capital (equity and debt)
2

The company declared negative results in Jun'24 after positive results in Dec'23

3

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 77 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.28

stock-summary
Return on Equity

-3.34%

stock-summary
Price to Book

1.03

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.5%
0%
2.5%
6 Months
11.82%
0%
11.82%
1 Year
60.78%
0%
60.78%
2 Years
92.19%
0%
92.19%
3 Years
80.88%
0%
80.88%
4 Years
76.98%
0%
76.98%
5 Years
-33.87%
0%
-33.87%

Venture Life Group Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.28%
EBIT Growth (5y)
-182.68%
EBIT to Interest (avg)
2.35
Debt to EBITDA (avg)
0.69
Net Debt to Equity (avg)
0.26
Sales to Capital Employed (avg)
0.44
Tax Ratio
7.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.77%
ROE (avg)
3.70%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.94
EV to EBIT
-92.08
EV to EBITDA
18.39
EV to Capital Employed
0.96
EV to Sales
2.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.39%
ROE (Latest)
-3.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Venture Life Group Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 16.82% vs 34.15% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 80.00% vs -79.17% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "51.40",
          "val2": "44.00",
          "chgp": "16.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.10",
          "val2": "8.60",
          "chgp": "29.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "1.50",
          "chgp": "46.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.30",
          "val2": "-1.10",
          "chgp": "-18.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.90",
          "val2": "0.50",
          "chgp": "80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "86.50%",
          "val2": "72.20%",
          "chgp": "1.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
51.40
44.00
16.82%
Operating Profit (PBDIT) excl Other Income
11.10
8.60
29.07%
Interest
2.20
1.50
46.67%
Exceptional Items
-1.30
-1.10
-18.18%
Consolidate Net Profit
0.90
0.50
80.00%
Operating Profit Margin (Excl OI)
86.50%
72.20%
1.43%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 16.82% vs 34.15% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 80.00% vs -79.17% in Dec 2022

stock-summaryCompany CV
About Venture Life Group Plc stock-summary
stock-summary
Venture Life Group Plc
Pharmaceuticals & Biotechnology
Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. Its product range includes the UltraDEX and Dentyl oral care range, which is primarily sold in the United Kingdom through the pharmacy and grocery retailers. Its product range also includes food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing and medical devices for conditions, such as hemorrhoids, minor aches and pains, and women's intimate health issues. It also provides development and manufacturing services to other companies in the healthcare and skincare sectors.
Company Coordinates stock-summary
Company Details
Unit 12, The Courtyard, Eastern Road , BRACKNELL None : RG12 2XB
stock-summary
Tel: 44 1344 578004
stock-summary
Registrar Details